Signaling lymphocyte activation molecular family 7 (SLAMF7) has been identified as a non-negligible component of CD47-mediated macrophage clearance of hematopoietic tumor cells (Chen et al., 2017). This evidence concerns the gene CD47 and hematopoietic and lymphoid system neoplasm.